Moderna raises 2021 sales forecast for COVID-19 vaccine to $19.2 billion

06/05/2021 Content pro, Moderna, results, US

FILE PHOTO: A healthcare worker holds a vial of the Moderna COVID-19 Vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in Manhattan in New York City, New York, U.S., January 29, 2021. REUTERS/Mike Segar

(Reuters) – Moderna Inc raised its 2021 sales forecast for its COVID-19 vaccine by 4.3% to $19.2 billion on Thursday, reflecting demand from countries looking to return to normalcy through rapid inoculation.

Earlier this week, Larger rival Pfizer Inc said it expects $26 billion in sales of its COVID-19 vaccine this year.

Moderna had in February forecast vaccine sales of $18.4 billion.

Since then, wealthy nations have been stocking up shots from Moderna and Pfizer Inc/BioNTech SE after safety concerns and production problems temporarily sidelined AstraZeneca Plc and Johnson & Johnson vaccines.

In the first quarter ended March 31, Moderna’s vaccine brought in sales of $1.7 billion.

The company said it plans to file for full approval of the vaccine in the United States this month.

Source: Read Full Article